BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19542765)

  • 1. Effect of suplatast tosilate on antileukotriene non-responders with mild-to-moderate persistent asthma.
    Wada M; Nagata S; Kudo T; Shimizu T; Yamashiro Y
    Allergol Int; 2009 Sep; 58(3):389-93. PubMed ID: 19542765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids.
    Sano T; Nakamura Y; Yanagawa H; Bando H; Nii A; Yoshida S; Sone S;
    Lung; 2003; 181(4):227-35. PubMed ID: 14692563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
    J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
    Tamaoki J; Kondo M; Sakai N; Aoshiba K; Tagaya E; Nakata J; Isono K; Nagai A
    Lancet; 2000 Jul; 356(9226):273-8. PubMed ID: 11071181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
    Kimata H
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
    Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma.
    Shioya T; Satake M; Sano M; Kagaya M; Watanabe A; Sato K; Ito T; Ito N; Sasaki M; Miura M
    Eur J Clin Pharmacol; 2002 Jun; 58(3):171-6. PubMed ID: 12107601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn: a pilot study.
    Yoshihara S; Yamada Y; Fukuda H; Tsuchiya T; Ono M; Fukuda N; Kanno N; Arisaka O
    Allergol Int; 2014 Jun; 63(2):199-203. PubMed ID: 24561769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7. Control of allergic airway inflammation through immunomodulation.
    Corry DB; Kheradmand F
    J Allergy Clin Immunol; 2006 Feb; 117(2 Suppl Mini-Primer):S461-4. PubMed ID: 16455347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
    Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
    Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-inflammatory drugs for the treatment of bronchial hyperresponsiveness].
    Sano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():48-53. PubMed ID: 9216184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
    Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
    Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
    Zeiger RS; Szefler SJ; Phillips BR; Schatz M; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM;
    J Allergy Clin Immunol; 2006 Jan; 117(1):45-52. PubMed ID: 16387583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term monotherapy with suplatast tosilate in patients with mild atopic asthma: a pilot comparison with low-dose inhaled fluticasone.
    Shiga M; Horiguchi T; Kondo R; Miyazaki J; Hirose M; Otake Y; Hata H; Tachikawa S
    Asian Pac J Allergy Immunol; 2011 Jun; 29(2):134-42. PubMed ID: 21980828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.